A detailed history of Fmr LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Fmr LLC holds 2,353,091 shares of CRSP stock, worth $117 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,353,091
Previous 2,239,683 5.06%
Holding current value
$117 Million
Previous $153 Million 16.75%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$51.17 - $68.18 $5.8 Million - $7.73 Million
113,408 Added 5.06%
2,353,091 $127 Million
Q1 2024

May 13, 2024

BUY
$60.67 - $89.12 $24.3 Million - $35.6 Million
399,812 Added 21.73%
2,239,683 $153 Million
Q4 2023

Feb 13, 2024

SELL
$38.62 - $72.18 $8.4 Million - $15.7 Million
-217,543 Reduced 10.57%
1,839,871 $115 Million
Q3 2023

Nov 13, 2023

SELL
$45.39 - $59.0 $1.53 Million - $1.99 Million
-33,759 Reduced 1.61%
2,057,414 $93.4 Million
Q2 2023

Aug 11, 2023

SELL
$43.47 - $67.77 $2.08 Million - $3.25 Million
-47,883 Reduced 2.24%
2,091,173 $117 Million
Q1 2023

May 11, 2023

SELL
$41.0 - $56.12 $1.86 Million - $2.54 Million
-45,328 Reduced 2.08%
2,139,056 $96.7 Million
Q4 2022

Feb 13, 2023

BUY
$39.19 - $65.67 $1.49 Million - $2.49 Million
37,940 Added 1.77%
2,184,384 $88.8 Million
Q3 2022

Nov 10, 2022

BUY
$61.1 - $83.78 $32.2 Million - $44.2 Million
527,422 Added 32.58%
2,146,444 $140 Million
Q2 2022

Aug 12, 2022

BUY
$43.23 - $73.83 $15.5 Million - $26.4 Million
357,400 Added 28.33%
1,619,022 $98.4 Million
Q1 2022

May 13, 2022

BUY
$53.19 - $79.24 $47.4 Million - $70.6 Million
890,900 Added 240.31%
1,261,622 $79.2 Million
Q4 2021

Feb 14, 2022

SELL
$70.09 - $111.29 $14.3 Million - $22.7 Million
-203,759 Reduced 35.47%
370,722 $28.1 Million
Q3 2021

Nov 15, 2021

SELL
$110.2 - $156.64 $247,509 - $351,813
-2,246 Reduced 0.39%
574,481 $64.3 Million
Q2 2021

Aug 13, 2021

BUY
$100.84 - $161.89 $58.2 Million - $93.4 Million
576,727 New
576,727 $93.4 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.87B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.